Pioneering studies have found that the presence of oxidized pyrimidine nucleotides in the CD34+ cells of patients with MDS and the oxidized pyrimidines were closely related to increased plasma tumor necrosis factor-α and low concentration of GSH in BM mononuclear cells [169]. The gene discussed is CD34; the disease is myelodysplastic syndrome.